IBA Molecular North America Flagged for GMP, Quality Issues

Drug GMP Report
A A
A PET finished dose manufacturer in Ohio was cited by the FDA after investigators witnessed numerous cGMP violations and potential quality problems on a January 2014 site visit.

To View This Article:

Login

Subscribe To Drug GMP Report